Analysis
Vulcan Energy’s Ludwig Math Is Compelling — The Market Needs More Than Numbers
The gap between engineering milestones and share-price performance at Vulcan Energy has rarely been wider. The lithium-geothermal developer has just...
Telekom’s Triple Leadership Shuffle Adds a New Wrinkle to the Elliott Standoff
The battle over Deutsche Telekom's future is no longer just about what happens in America. A sweeping overhaul of the...
Almonty’s Sangdong Transition: The Gap Between Analyst Targets and Ore That Actually Moves
There comes a point in every mining story when the narrative shifts from what a company says it will do...
Arafura Rare Earths Trims Nolans Price Tag by A$200 Million as Funding Clock Ticks Toward October
The arithmetic of building a rare earths mine from scratch in Australia's Northern Territory rarely stays static, but Arafura Rare...
Nvidia’s $35 Billion Shadow: How the Chip Giant Became AI’s Silent Power Broker
Wall Street's bull case for Nvidia has never been more straightforward: Rosenblatt Securities reaffirmed its "Buy" rating on Sunday with...
BMW’s Autumn of Recalibration: New Leadership, Record Range, and a Stock Still Climbing Out of a Hole
The BMW share price has spent much of 2025 in recovery mode, and the closing bell on Friday offered another...
Circus SE’s Boardroom Signal Clashes With a Market That Still Isn’t Buying It
Jürgen Thamm's arrival on the Circus SE board came with a mandate that had nothing to do with optics. The...
D-Wave Quantum: When Lab Breakthroughs and Balance-Sheet Realities Pull in Opposite Directions
There is a peculiar irony at the heart of D-Wave Quantum's current predicament. The same week the company's stock touched...
BASF’s Multifront Week: Analyst Optimism, Price Hikes, and a Renewed Legal Push Against Apple
The German chemicals giant is navigating a dense stretch of corporate activity, with developments arriving simultaneously across the capital markets,...
Novo Nordisk’s Oral Wegovy Push Hits Germany and China as the Bull-Bear Battle Widens
The Danish pharma giant is placing its biggest strategic bet on a pill — but the market is still weighing...
Popular News
-
SunHydrogen Set for European Debut with Groundbreaking Technology
-
Walgreens Implements Deep Restructuring Following Private Buyout
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize
-
Kraft Heinz Stock: A Contradiction in Market Sentiment
